Received date: November 29, 2016; Accepted date: December 26, 2016; Published date: December 29, 2016
Citation: Reyad-Ul-Ferdous Md, Rahman M, Rahman MA, et al. Phytochemical Screening and Ex-Vivo Cardioprotective Assay of Euphorbia hirta (L). Cell Mol Med 2016, 2:3.
Investigated whole plant extracts of Euphorbia hirta L were used for it possible phytochemistry as well as thrombolysis effect by using its water, ethyl acetate and ethanolic fractioned extracts. Pharmacological history of this plant promoted us to check the possible thrombolysis activities. This article demonstrated the thrombolytic activities of various extracts of Euphorbia hirta L. Whereas ethanol, ethyl acetate and water extracts demonstrated clot lysis 25.81%, 14.17% and 30.48 % respectively. Different conformity tests of the crude extract demonstrated that Euphorbia hirta L consists of various types of glycosides, alkaloids, tannins, flavonoids, triterpenoids etc. In-vitro Euphorbia hirta lyses blood clots. Once found Euphorbia hirta may be integrated as a thrombolytic moiety for the treatment for atherothrombotic diseases. However, the present in-vitro biological evaluation of this plant forms a primary platform for further phytochemical and pharmacological studies. These potential extracts may play vital roles for discovery new clinically effective bioactive compounds. Further investigation might be elucidating, identification of cellular and molecular mechanism of action and purification of active compounds and binding capacity of active molecules with receptors.
Euphorbia hirta Lnn; Phytochemistry; Cardioprotective activities; Bangladesh
An important medicinal herb (Euphorbia hirta), belongs to family Euphorbiaceae . Commonly functional to cure various diseases, like as intestinal diarrhea, parasites, vomiting, heartburn, amoebic dysentery and peptic ulcers, warts, tinea, scabies, fungal afflictions, thrush, and measles, aphthae, as well as respiratory system disorders (including emphysema, asthma, bronchitis, laryngeal spasms, coughs, colds and hay fever) [2,3]. Several phytochemical studies revealed that E. hirta contains vital phyto-constituents like as quercitrin, rutin, myricitrin, gallic acid euphorbin-A, quercitin, and β-amyrin, 24-methylenecycloartenol, β-sitosterol, ephorbin-B, euphorbin-C, euphorbin-D, heptacosane, n-nonacosane [4,5] tinyatoxin, shikmic acid, choline, camphol, afzelin and quercitol derivatives containing chtolphenolic acid and rhamnose .The polyphenolic extract of E. hirta has antiamoebic  and antispasmodic activity  Quercitrin, a flavanoid glycoside, isolated from the herb showed an antidiarrheal activity [9-11]. It is reported to have a relaxation effect on respiration . The alcoholic extract of whole plant shows hypoglycemic activity in rats . It has a sedative effect on the genitor-urinary tract . Modern studies reveal that E. hirta herb shows anti-inflammatory, antimalarial, antibacterial, antiasthmatic, antidiarrheal, galactogenic, anticancer, antifertility, antioxidant, antifungal and antiamoebic activities . Further research needs to isolation purifications of lead compounds as well as mechanisms of actions of E. hirta.
Plant material preparation
The plant material named as E. hirta was selected based on its medicinal uses the plant’s leaves were identified by the Bangladesh Forest Research Institute (BFRI), Chittagong. The plants were collected from phartoly Chittagong. It was then separated and cleaned from impurities. The collected plant was dried under shadow in room temperature and then macerated (37°C ± 2°C) for 3 hours at hot air oven. Almost 250 gm powders crude extracts were dissolved in 500 ml methanol (95%) following cold extraction for further used . Afterward dissolved extract was kept couple of days under shaker for proper dissolution then solutes filtered through Buchner funnel then again dried for evaporation of methanol at water bath (40°C) and extracts were preserved at <4°C for further used .
Primary phytochemical screening
The powdered form of the plant extracts was conducted for phytochemicals test following methods described by Md. Reyad-ul-ferdous [16-19]. The test was done to find the presence of active constituents such as flavonoid, triterpenoids, alkaloids, steroids, tannin, and glycoside by the following procedure:
Test for flavonoids: A small amount of an alcoholic extract of the plant material was treated with a few drops of concentrated hydrochloric acid. Besides concentrated hydrochloric acid, Mg was added in order to realize flavonoids detection. A red color was developed immediately, which show the existence of flavonoids 1 gm extracts were dissolved in 50 ml water for further phytochemical screening.
Test for glycosides: Little amount of an alcoholic extract was dissolved in 1 ml of water and inserted a few drops (aqueous sodium hydroxide solution) which developed yellow color which demonstrated presence of glycosides in plant.
Test for alkaloids: Almost 0.5 gm of the extract was added in 5 ml of 1% hydrochloric acid stirred on a steam bath and filtered; few drops of potassio-mercuric iodide solution (Mayer's reagent) were added in 1 ml of that filtrate. A white or creamy white precipitate was formed which specify the existence of alkaloids in plant.
Test for tannins: 1 ml 5% ferric chloride solutions were added in 5 ml crude extract then orange precipitate was formed which specify the existence of tannins.
Tests for carbohydrates:
Molisch's test: Freshly prepared 10% alcoholic solution of alpha-naphtha (2 drops) was added in a test tube containing 2 ml of an aqueous extract of the plant material and mixed thoroughly. 2 ml of concentrated Sulfuric acid was added of inclined test tube and observed a layer below the aqueous solution. If a carbohydrate is present, then a red or reddish violet ring was formed at the junction of the two layers. On standing or shaking a dark purple solution was produced then it was shaken and allowed to stand for two minutes afterward diluted with water (5 ml). Immediate a dull violet precipitate was formed which indicates the presence of carbohydrates.
Benedict's test: In 0.5 ml of an aqueous extract of the plant material added 5 ml of Benedict's solution. Then it was boiled for 5 minutes and allowed to cool spontaneously. Cuprous oxide red precipitate was developed which indicates the existence of reducing sugar.
Test for resins: A few amounts of chloroform or ethanolic crude extract was dissolved in 5 ml to 10 ml of acetic anhydride followed by gentle heat. It was cooled and 0.05 ml of sulfuric acid was added then no bright purplish red color was produced which indicates the absence of resins.
Test for anthraquinone glycosides: 5 ml of chloroform shaken with 0.5 gm of the powdered plant bark in a test tube for at least 5 minutes and filtered. An equal volume of filtrate and 10% ammonia solution was shaken. No bright pink formation, violet or red color in the aqueous (upper) layer specifies the absence of free anthraquinones.
Salkowskis test: 2 ml of crude chloroform extract carefully added in 1 ml of concentrated sulphuric acid of the inclined test tube. A red color is formed in the chloroform layer if steroids are present.
The thrombolytic properties were performed for evaluation of cardioprotective drugs moieties. All the crude extract was evaluated for thrombolytic activity by the method and modified by Md. Reyad-ul-Ferdous  by using standard streptokinase (SK). In brief, 100 mg plant extracts were suspended in distilled water (10 mL) then kept overnight. The soluble supernatant was collected and filtered by using a 0.22 μ syringe filter for further use. 500 μL venous blood drawn from human healthy volunteers and scattered in different sterile pre-weighed micro-centrifuge tube for clot lysis then incubated at 37°C for 45 minutes for clot formation. The serum was completely removed without disturbing the clot, after clot formation and the clot weight was determined. Each microcentrifuge tube with the pre-weighed clot was added by 100 μL aqueous solutions of different partitioned and crude extracts. Then, 100 mg of distilled water and 100 μL (30,000 I.U) of commercial streptokinase (SK) were separately added to the control tube as negative and positive controls, correspondingly.
All the micro-centrifuge tubes were kept for 90 minutes at 37°C incubation and observed for clot lysis. The released fluid was removed after incubation and tubes were reweighed to examine the difference in weight after clot disruption.
% of clot lysis was calculated by given formula:
% of clot lysis = (weight of released clot/clot weight) × 100
% of clot lysis = (weight of released clot/clot weight) × 100
Herbal extracts of Euphorbia hirta clot lysis percentage was conducted by paired t-test analysis (SPSS-20). Whereas clot lysis is demonstrated as a percentage as well as p value <0.0001 was considered as significant.
Euphorbia hirta ethanol extract of the bark were performed qualitative phytochemical tests. The Euphorbia hirta revealed of several chemical tests for the detection and identification of chemical moieties are mentioned in the Table 1.
|Test||Plant Parts (Bark)|
|Carbohydrate test||Molisch's Test-Present|
Table 1 Chemical constituents identified in the bark extract.
The present phytochemical study indicates several potential phytochemical moieties available in the plant parts which are responsible for various pharmacological activities. These are potential phyto-constituents for vital medication against several diseases. Further investigation need to depth analysis for isolation, identification and purification of phytoconstituents and different mode of action [15-17].
In Addition, a positive control (1500000 I.U.) of 100 μl of streptokinase to the clots incubation at 37°C, along with 90 minutes which showed 69.35% clot lysis. Whereas negative control showed only negligible colt lysis (6.23%) Clots when treated with 100 μl sterile distilled water. After treatment of clot with Euphorbia hirta (E), Euphorbia hirta (EA) Euphorbia hirta (W) demonstrated 25.81%, 14.17% and 30.48% clot lysis respectively whereas mean percentage of clot lysis were more than water clot lysis. The thrombolytic properties are possibly due to the plant’s diverse moieties like as tannins, terpenoids and flavonoids .
Purification of the active principles of the plant leads for the observed biological effects . Euphorbia hirta herbal extracts demonstrated significance percent clot lysis with appropriate controls is shown Table 2.
(mean ± SD)
|P value with negative control (water)|
|Streptokinase (used as Positive control)||69.35 ± 1.88||<0.0001|
|Euphorbia hirta (E)||25.81 ± 4.22||<0.0001|
|Euphorbia hirta (EA)||14.17 ± 3.55||<0.0002|
|Euphorbia hirta (W)||30.48 ± 5.51||<0.0001|
Ethanol extracts=E, Ethyl-acetate extracts=EA, and water=W. Herbal extracts of Euphorbia hirta was statistically demonstrated significance clot lysis percentage that was conducted by paired t-test analysis (SPSS-20). Streptokinase used as positive thrombolytic control as well as sterile distilled water used as negative control. Whereas clot lysis is demonstrated as a percentage as well as p value <0.0001 was considered as significant
Table 2 Effect of herbal extracts on in vitro clot lysis.
Euphorbia hirta (Ethanol), Euphorbia hirta (Ethylacetate) and Euphorbia hirta (Water) demonstrated clot lysis 25.81%, 14.17% and 30.48% respectively. Euphorbia hirta lyses blood clots in vitro, however, in vivo clot dissolving properties yet to be discovered. Once found Euphorbia hirta may be incorporated as a thrombolytic agent for the improvement of the patients suffering from atherothrombotic diseases.
However, the present in vitro biological evaluation of this plant forms a primary platform for further phytochemical and pharmacological studies. These promissory extracts open the possibility of finding new clinically effective bioactive compounds. Further investigation might be elucidating, identification of molecular mechanism of action and purification of active compounds and binding capacity of active molecules with receptors as well as identify specific compound for this activity among existence compounds.
Blood samples were withdrawn from those healthy persons who were volunteers themselves and, after getting clearance from our institutional ethical committee.
All authors declare that there is no conflict of interest.
All authors were equally contributed
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2017 All rights reserved. iMedPub Last revised : October 18, 2017